Skip to content
PodParley
Time to Cilta-Cel-ebrate? episode artwork

EPISODE · Sep 4, 2025 · 10 MIN

Time to Cilta-Cel-ebrate?

from OncoPharm · host John Bossaer

The 5-year+ follow-up from CARTITUDE-1 has people asking if cilta-cel can cure multiple myeloma? We discuss this data and the broad comparison to the other BCMA-targeting CAR-T product, idi-cel and a recent comparison on plasma cell leukemia. CARTITUDE-1 Long-Term F/U: https://doi.org/10.1200/JCO-25-00760 Cilta-cel & ide-cel in plasma cell leukemia: https://doi.org/10.1182/bloodadvances.2025016966

Episode metadata supplied by the publisher feed · Published Sep 4, 2025

Embed this episode

Ready to play

Time to Cilta-Cel-ebrate?

0:00 10:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncoPharm?

This episode is 10 minutes long.

When was this OncoPharm episode published?

This episode was published on September 4, 2025.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!